TPS03 Antibody
Shipped with Ice Packs 
In Stock 
Product Specs
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
TPS03 antibody; At4g16740 antibody; dl4395w antibody; FCAALL.18 antibody; Tricyclene synthase antibody; chloroplastic antibody; EC 4.2.3.105; antibody; E)-beta-ocimene synthase antibody; EC 4.2.3.106; antibody; E,E)-alpha-farnesene synthase antibody; EC 4.2.3.46 antibody; Terpenoid synthase 3 antibody; AtTPS03 antibody
Target Names
TPS03
Uniprot No.
Target Background
Function
TPS03 is primarily involved in the biosynthesis of sesquiterpenes (C15). Utilizing farnesyl pyrophosphate (FPP) as a substrate, the primary product is (E,E)-alpha-farnesene, with minor amounts of (Z,E)-alpha-farnesene and (E,E)-beta-farnesene. When using geranyl pyrophosphate (GPP) as a substrate, TPS03 can also synthesize monoterpenes (C10) in vitro, with (E)-beta-ocimene as the major product and (Z)-beta-ocimene and myrcene as minor products.
Gene References Into Functions
- Variations in the relative emissions of (E)-beta-ocimene and (E,E)-alpha-farnesene from different accessions have been attributed to allelic variation within two closely related, tandem-duplicated terpene synthase genes, TPS02 and TPS03. [TPS03] PMID: 20463089
Database Links
Protein Families
Terpene synthase family, Tpsb subfamily
Subcellular Location
Cytoplasm. Plastid, chloroplast stroma.
Tissue Specificity
Predominantly expressed in flowers but also in leaves, roots, stems and siliques.
Q&A
Here’s a structured collection of FAQs for researchers working with the TPS03 Antibody, grounded in academic research scenarios and informed by methodological rigor:
Advanced Research Questions
How should data contradictions involving TPS03 Antibody be resolved?
What are best practices for cross-species TPS03 Antibody applications?
-
Validate reactivity using phylogenetic alignment of the target epitope .
-
Clearly state species-specific validation data in methods (e.g., murine vs. human samples) .
How can epitope mapping improve TPS03 Antibody experimental design?
| Method | Utility |
|---|---|
| Peptide array screening | Identifies exact binding regions to avoid off-target interactions . |
| Structural modeling | Predicts epitope accessibility in folded protein conformations . |
What protocols ensure TPS03 Antibody stability in long-term studies?
How to validate TPS03 Antibody in multiplex assays?
-
Use spectral deconvolution or sequential staining to avoid cross-talk .
-
Include single-antibody controls to confirm signal specificity .
Key Methodological Considerations
How should researchers address conflicting TPS03 Antibody literature findings?
Quick Inquiry
Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
